HOXA11-AS1

Add links
Source: Wikipedia, the free encyclopedia.

HOXA11-AS lncRNA is a

lncRNA, it is longer than 200 nucleotides in length, in contrast to regular non-coding RNAs.[3]

The HOX genes code for

embryogenesis and carcinogenesis, genes on the sense strand and antisense non-coding RNA (ncRNA) genes are often studied in their role of aberrant epithelial differentiation and cancer development.[5]

Location of HOXA11AS1 locus on chromosome 7

Function

Many lncRNAs are sequences that regulate the expression of nearby or distant genes. Common in HOX genes, lncRNAs can either regulate through

cis or trans mechanisms, respectively.[6] Cis mechanisms are transcription based when nearby genes are regulated, whereas trans mechanisms are transcript-based and regulate genes afar.[4][6] HOXA11-AS regulates transcription factors and is a co-activator of the HOXA gene and other genes. Coming from HOXA homeobox, HOXA11-AS lncRNA regulates HOXA11 mRNA by blocking transcription.[7]

HOXA11-AS is similar to other lncRNAs in that it can affect many genes at once, thus allowing both local and genome-wide control.[6] It is also similar because of its function in regulating cell proliferation, cell cycle, migration, apoptosis, and promoting angiogenesis.[1] Some studies have shown that overexpression causes aberrant functions of the mechanisms listed above; however, other studies have shown downregulation is the cause.[1][5]

Mechanism

Not much is known about the exact mechanism of HOXA11-AS lncRNA.

capped, polyadenylated
, and exported out of the nucleus.

Above: Cis regulation of nearby genes Below: Trans regulation of distant genes

Epigenetic proteins that are involved with lncRNAs are categorized as either: writers, readers, or erasers.[6] These proteins either add epigenetic modifications, recognize epigenetic changes, or remove epigenetic modifications, respectively. LncRNAs are able to complementarily hybridize to DNA sequences in the genome, thus targeting sequences and localizing epigenetic changes.[10] Oftentimes, lncRNAs are not free-floating in the nucleus and are attached to chromosomes.[2]

Studies regarding HOX genes have found that lncRNAs are highly expressed in relation to the

homeobox genes. Known antisense HOX lncRNAs, such as HOTAIR, are scaffolds where transcription factors bind, which makes them mediators of epigenetic regulation.[10][11] Furthermore, this and other HOX lncRNAs are required for the normal development of the organism and are overexpressed in different forms of cancer.[11] The overexpression of HOX lncRNA promotes cancer because it causes epigenetic regulator proteins to relocate and the chromatin of the cell to be remodeled.[10] This remodeling can cause highly regulated functions of the cell, like proliferation, migration, and apoptosis to become unrestrained.[6]
Given the sparse research on the specific mechanism of HOXA11-AS lncRNA and what is known about the role of HOX genes, it may hold that HOXA11-AS lncRNAs act in a similar manner to other HOX lncRNAs.

Cancer Research

HOXA11-AS has been reported to have roles in various different cancers, including

gastric cancer, colorectal cancer, glioma, and cervical cancer.[1] Some studies have indicated that lncRNAs can be markers or targeted for treatment in various types of cancers.[4]

Breast Cancer

Tissue samples of patients with breast cancer show high expression levels of HOXA11-AS, indicating its carcinogenic nature.[7][12] Evidence of over-expression of HOXA11-AS as a causative factor of cell proliferation is seen when proliferation is blocked, once the lncRNA expression is knocked-down, or removed. Manipulating or removing the expression of this lncRNA allowed scientists to halt the progression of the cell cycle and initiate cell apoptosis at common cellular checkpoints, such as G1/G0 stage.[7][12] The expression of the lnRNA was also suppressed by using small interfering RNAs (siRNA), that would degrade HOXA11-AS lnRNA transcripts. Upon doing so, cell proliferation was blocked.[7] In addition to interfering with proliferation, degradation of HOXA11-AS lncRNA with siRNA was also seen to influence cell migration and cell tumor invasion, which is cancer metastasis.[7][12] Scientists were able to determine these effects of HOXA11-AS lncRNA on breast cancer by monitoring the changes of epithelial-mesenchymal markers in the cell. Current research is looking at the potential possibility that breast cancer can be controlled or blocked by regulating the interaction between the lnRNA and epithelium/mesenchyme.[12]

Lung Cancer

In

NSCLC), researchers found that HOXA11-AS plays a role as an oncogene, and that patients who had decreased HOXA11-AS lncRNA had a greater survival time. In addition, HOXA11-AS lncRNA was found to be up-regulated in the lung tissue of patients with NSCLC.[1]
HOXA11-AS lncRNA was found to inhibit apoptosis, promote cancer cell proliferation, promote cell migration, and activate the cell cycle.

Ovarian Cancer

HOXA11-AS lncRNA is studied in cancer research since its over-expression has been reported in epithelial ovarian cancer (EOC). In addition, on the molecular level, single nucleotide polymorphisms (SNPs) have also been observed in the lncRNA sequences of HOXA11-AS in EOC patients. Studies have shown that the SNP variants in these lncRNA sequences do not increase risk of EOC in patients, but may be the driving force of the cancer phenotype.[5]

Regularly, HOXA11-AS lncRNA is a tumor-suppressor that inhibits EOC proliferation and migration; however, in many EOC cases, researchers observed downregulation of the lncRNA in the ovarian tissue.

Gastric Cancer

HOXA11-AS has been shown to be significantly up-regulated in

beta-catenin through its interaction with EZH2.[14] Additionally, current research has found that HOXA11-AS interacts with miR-1297 and blocks its ability to repress EZH2 protein translation.[13]

Colorectal Cancer

Tissue samples from patients with colorectal cancer (CRC) were observed to have decreased expression of HOXA11-AS lnRNA when compared to normal colon cells.[8] Correlations were seen between patients with larger tumor size, higher carcinoembryonic antigen (CEA), and increased metastases to decreased expression of the lncRNA.[8] These metastases were tumor-node metastases (TNM) and lymphatic metastases. Lymphatic metastases is significant, as it is a common route for cancer cells to migrate to other parts of the body.[15] Scientists were able to determine the effect HOXA11-AS lnRNA had on migration by blocking the transcript with siRNA and observing decreased cell migration and invasion.[16] There was no correlation found between the migration distance and decreased HOXA11-AS lnRNA expression.[8]

See also

  • Long noncoding RNA

References

  1. ^
    PMID 28717185
    .
  2. ^
    PMID 22096659
    .
  3. PMID 21393997
    .
  4. ^
    PMID 23463798
    .
  5. ^
    PMID 26430965
    .
  6. ^
    PMID 17174895
    .
  7. ^
    PMID 28791375
    .
  8. ^
    PMID 27895785
    .
  9. PMID 25276098
    .
  10. ^
    ISBN 978-0-19-967139-7
    .
  11. ^
    PMID 25859406
    .
  12. ^
    PMID 28701685
    .
  13. ^
    PMID 27651312
    .
  14. PMID 28441948
    .
  15. PMID 25961925
    .
  16. PMID 29050308
    .
Retrieved from "https://en.wikipedia.org/w/index.php?title=HOXA11-AS1&oldid=1187420892"